<DOC>
	<DOCNO>NCT02222558</DOCNO>
	<brief_summary>Low testosterone condition occur body unable produce sufficient quantity testosterone . The medical name low testosterone hypogonadism . Hypogonadism cause many factor . Symptoms include : decrease libido , lack energy mood swing . The goal testosterone replacement therapy return testosterone level normal range relieve symptom .</brief_summary>
	<brief_title>Oral Testosterone Treatment Hypogonadism Males</brief_title>
	<detailed_description>The purpose study evaluate pharmacokinetic ( PK ) parameters testosterone administration TSX-002 ( easy swallow testosterone capsule ) hypogonadal men . This determine blood sampling specify time study . The study also intend evaluate PK parameter testosterone metabolite , dihydrotestosterone ( DHT ) , well safety tolerability TSX-002 . The study consist three ( 3 ) period , TSX-002 take orally various dos . Study duration approximately 9 week .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Symptomatic hypogonadal male subject ( Testosterone &gt; 100 &lt; 300 ng/dL , two separate 10 sample one week apart ) , 1870 year old , Willing able provide inform consent participate 3 period study . BMI &lt; 35 kg/m2 . Malabsorption condition ( e.g . history cholecystectomy , Inflammatory Bowel Disease , Pancreatitis , Celiac disease , Sprue , Dumping syndrome , Bariatric surgery ; Short bowel syndrome , Lactose intolerance ) ; Alcoholics substance abuse ; Gastroparesis ; IPSS ( International Prostate Symptom score ) &gt; 19 ; PSA ( prostatespecific antigen ) &gt; 4 ng/ml ; Congestive Heart Failure , uncontrolled ( NYHC &gt; 1 ) ; Uncontrolled sleep apnea ; Topical injectable testosterone replacement therapy ( kind include dehydroepiandrosterone ( DHEA ) nutritional supplement ) within past 4 week ; Testopel exclude within 2 year ; Aveed exclude within past 6 month ; Hematocrit &gt; 50 .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>Gonadal Disorders</keyword>
	<keyword>Endocrine System Diseases</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Testosterone enanthate</keyword>
	<keyword>Testosterone undecanoate</keyword>
	<keyword>Testosterone 17 beta-cypionate</keyword>
	<keyword>Methyltestosterone</keyword>
	<keyword>Androgens</keyword>
	<keyword>Hormones</keyword>
	<keyword>Hormones ,</keyword>
	<keyword>Hormone Substitutes ,</keyword>
	<keyword>Hormone Antagonists</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Anabolic Agents</keyword>
	<keyword>dihydrotestosterone</keyword>
</DOC>